Alector is based out of South San Francisco. Alector, Inc. operates as a clinical stage biopharmaceutical company. The Company researches and develops novel therapeutics for the treatment of neurodegeneration and other brain disorders. Alector offers its services in the State of California. The firm last filed a Form D notice of exempt offering of securities on 2015-09-16. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
Alector, Inc.131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO CA 94080
Business Phone: 415-231-5660
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)